‘New drug lowers deadly Huntington’s disease protein’
Team Udayavani, Dec 12, 2017, 4:50 PM IST
London: In a ‘ground-breaking’ development, scientists have developed a drug that can treat Huntington’s disease by lowering the level of the harmful protein in the nervous system. Huntington’s disease is characterised by the progressive loss of nerve cells in the brain. This fatal disorder is caused by a hereditary defect in a single gene.
IONIS-HTTRx successfully lowered the level of the harmful huntingtin protein in the nervous system. The first human trial of the huntingtin-lowering drug began in late 2015 by researchers from the University College London in the UK.
The trial involved 46 patients with early Huntington’s disease at nine study centres in the UK, Germany and Canada. Each patient received four doses of either IONIS-HTTRx or placebo, given by injection into the spinal fluid to enable it to reach the brain.
As the phase 1/2a trial progressed, the dose of IONIS- HTTRx was increased several times according to the ascending- dose trial design. IONIS-HTTRx was well-tolerated by the trial participants and its safety profile supported further testing in patients.
“The results of this trial are of ground-breaking importance for Huntington’s disease patients and families,” said Sarah Tabrizi, from the University College London. “For the first time a drug has lowered the level of the toxic disease-causing protein in the nervous system, and the drug was safe and well-tolerated. The key now is to move quickly to a larger trial to test whether the drug slows disease progression,” Tabrizi said.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Nearsightedness is at epidemic levels – and the problem begins in childhood
Study finds genetic basis for link between depression, heart disease
World Malaria Day: WHO calls for equitable health access
What role does genetics play in breast cancer? How can genetic testing help with early breast cancer diagnosis?
Father’s diet can affect anxiety in sons, metabolism in daughters: Study in mice finds
MUST WATCH
Latest Additions
With impact player, it is getting difficult each and every day: Pant
Congress in K’taka to stage protest on Apr 28 against ‘paltry’ drought relief given by Centre
McGurk, Stubbs rock as DC beat MI by 10 runs
‘Shaurya Smarak’ of three fallen Army officers unveiled in Jammu
BJP drops Poonam Mahajan, picks 26/11 prosecutor Ujjwal Nikam from Mumbai North Central seat